JMI LABS IS NOW PART OF LEARN MORE

GAR-936 (9-t-butylglycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: Preliminary guidelines and interpretive criteria. by Deshpande LM, Gales AC and Jones RN published in Int. J. Antimicrob. Agents 2001; 18 (1): 29-35

View publication